What is the NAV of Nippon India Pharma Fund?
The Current NAV of Nippon India Pharma Fund is ₹571.88, as of 13th June 2025What are the returns of Nippon India Pharma Fund?
The Nippon India Pharma Fund has been there since 1st January 2013- 1 Year Returns: 14.76
- 3 Year Returns: 26.64
- 5 Year Returns: 23.13
What are the top 5 sectors holdings of Nippon India Pharma Fund?
The top sectors Nippon India Pharma Fund has invested in are as for 1st 01 2013 are as follows -- Pharmaceuticals | 79.45%
- Labs & Life Sciences Services | 18.26%
- Miscellaneous | 1.52%
- Others | 0.77%
What are the top 5 holdings Nippon India Pharma Fund?
The top 5 holdings for Nippon India Pharma Fund are- Sun Pharmaceutical Industries Ltd | 12.57%
- Divi's Laboratories Ltd | 9.49%
- Lupin Ltd | 5.82%
- Cipla Ltd | 5.62%
- Dr. Reddy's Laboratories Limited | 5.49%
What is the asset allocation of Nippon India Pharma Fund?
The Nippon India Pharma Fund is a plan that invests- Equity | 98.58%
- Cash & Equivalents | 1.42%
How to invest in Nippon India Pharma Fund?
If you wish to invest in Nippon India Pharma Fund Plan via smallcase, you can follow these quick and easy steps -- Log in to smallcase
- Search and select the Nippon India Pharma Fund
- Complete filling your details and KYC
- Enter the Amount and type of investment (SIP or Lumpsum)
- And Voila! your SIP or Lumpsump investment in Nippon India Pharma Fund is completed
You can also calculate the returns on your investment based on our smallcase Lumpsum & SIP Calculator.
What is the AUM of Nippon India Pharma Fund?
The AUM of Nippon India Pharma Fund is 8259.60 Cr as of 13th June 2025What is the expense ratio of Nippon India Pharma Fund Plan?
The expense ratio of Nippon India Pharma Fund Plan is 0.89How to exit Nippon India Pharma Fund?
If you have invested in Nippon India Pharma Fund, then simply visit your investment and you will find an option to exit the funds or invest more. Please click on 'exit' and add the amount or units. In case you want to exit from all units, you can simply click on the checkbox option shown.What is the alpha of Nippon India Pharma Fund?
The alpha ratio for the Nippon India Pharma Fund is 0.02
Alpha is the excess return of a fund compared to its expected return based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the Volatility or Standard Deviation of Nippon India Pharma Fund?
The volatility or standard deviation for the Nippon India Pharma Fund is 14.70
Standard Deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of Nippon India Pharma Fund?
The sharpe ratio for the Nippon India Pharma Fund is 0.76
The Sharpe Ratio is a measure of risk-adjusted return that evaluates the performance of an investment, such as a mutual fund, by adjusting for its risk. Higher Sharpe Ratio, indicates a better risk-adjusted performance. A positive Sharpe Ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe Ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of Nippon India Pharma Fund?
The Sortino ratio for the Nippon India Pharma Fund is 0.08
The Sortino ratio is a measure of risk-adjusted return for an investment, such as a mutual fund.
What is the Price to Earnings (PE) of Nippon India Pharma Fund?
The PE ratio (price-to-earnings) of the Nippon India Pharma Fund is 47.44 while category PE ratio is 53.461. Test MF FAQ for Mutual Fund Nippon India Pharma Fund Shares?
The Current NAV of Nippon India Pharma Fund is ₹571.88, as of 13th June 20255. Test MF FAQ Is there any lock-in period for Nippon India Pharma Fund Plan?
There is a lock in period of N/A for Nippon India Pharma Fund
How to use scorecard? Learn more
Nippon India Pharma Fund Direct Growth
How to use scorecard? Learn more
Nippon India Pharma Fund Performance & Key Metrics
Nippon India Pharma Fund Performance & Key Metrics
| Expense RatioExpense Ratio | No LabelNo Label | No LabelNo Label |
|---|---|---|
| 0.89 | 47.44 | 0.76 |
| No LabelNo Label | No LabelNo Label | No LabelNo Label |
|---|---|---|
| 1.49 | 53.46 | 0.65 |
Nippon India Pharma Fund Scheme InfoNippon India Pharma Fund Scheme Info
| PlanPlan | Lock inLock in | Exit LoadExit Load |
|---|---|---|
| Growth | 0 yrs | 1.00% |
| SIP Inv.SIP Inv. | Min. LumpsumMin. Lumpsum |
|---|---|
| Allowed | ₹ 5,000 |
| BenchmarkBenchmark |
|---|
| BSE Health Care - TRI |
About Sector Funds - Pharma & Health Care
About Sector Funds - Pharma & Health Care
Sector Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.
Nippon India Pharma Fund Peers
What are peers and why compare against them?
What are peers and why compare against them?
A mutual fund’s peers are schemes which belong to the same category. Comparing various metrics against peers can give valuable insights on how the scheme is performing as compared to the scheme category as a whole.
Nippon India Pharma Fund Peers & Comparison
EquitySector Funds - Pharma & Health Care
Returns
Scheme
Ratios
| Mutual Fund | 1Y Returns1Y Returns | 3Y CAGR3Y CAGR | Life CAGRLife CAGR |
|---|---|---|---|
| Nippon India Pharma Fund | 14.76% | 26.64% | 18.40% |
| ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund | 22.98% | 30.89% | 23.19% |
| SBI Healthcare Opp Fund | 20.56% | 30.50% | 18.30% |
| DSP Healthcare Fund | 17.98% | 28.00% | 24.72% |
Nippon India Pharma Fund Returns Comparison
Compare Nippon India Pharma Fund with any MF, ETF, stock or index
Hmm, looks like data is unavailable here. Please come back after some timeNippon India Pharma Fund Portfolio
What are constituents?
What are constituents?
Mutual fund constituents are the various stocks, bonds, and other securities held within a fund. The size and mix of holdings depend on the category or type of fund. The holding analysis can give valuable understanding regarding the diversification of the fund.
Nippon India Pharma Fund Asset Allocation
Nippon India Pharma Fund Asset Allocation
Actual
Target
Sep 2024
Dec 2024
Mar 2025
May 2025
Sep 2024
Dec 2024
Mar 2025
May 2025
Nippon India Pharma Fund Sector Distribution
Nippon India Pharma Fund Sector Distribution
Sep 2024
Dec 2024
Mar 2025
May 2025
Nippon India Pharma Fund Sector Weightage
Nippon India Pharma Fund Sector Weightage
Nippon India Pharma Fund Current Holdings
Nippon India Pharma Fund Current Holdings
Equity
Others
- ConstituentHolding Weight3M Change
Holdings
12.57 %
-1.11 %Holdings
9.49 %
0.17 %Holdings
5.82 %
-1.90 %
AMC Profile of Nippon India Pharma Fund
AMC Profile of Nippon India Pharma Fund
Reliance Nippon Life Asset Management or RNAM is one of India’s two largest asset management companies. Currently, it has over $60 billion in its corpus. It is a wholly owned subsidiary of the Reliance Anil Dhirubhai Ambani or ADA Group.
Reliance Nippon Life Asset Management or RNAM is one of India’s two largest asset management companies. Currently, it has over $60 billion in its corpus. It is a wholly owned subsidiary of the Reliance Anil Dhirubhai Ambani or ADA Group.
No.of Schemes
76
Total AUM
₹ 4,40,712.48 Cr.
Nippon India Pharma Fund Manager Details
Nippon India Pharma Fund Manager Details
Nippon India Pharma Fund Manager Profile
Nippon India Pharma Fund Manager Profile
Sailesh Raj Bhan
AUM: ₹93,492.92 Cr.
|
Exp: 10yrs
Qualification
MBA (Finance), CFA (ICFAI)
Past Experience
Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date
Funds Managed (6)
Nippon India Pharma Fund Manager Performance (0)
Nippon India Pharma Fund Manager Performance (0)
Nippon India Pharma Fund Tax Implications
Nippon India Pharma Fund Tax Implications
Investment frequency
Monthly
One Time
Monthly Investment Amt. (₹)
Investment period (years)
You make
Nippon India Pharma Fund Review & Opinions
Nippon India Pharma Fund Review & Opinions
Hmm, looks like data is unavailable here. Please come back after some time.
Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%